| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.3910 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.4095 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.4309 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.4412 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.4814 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5007 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5129 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5270 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5300 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5326 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5328 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5427 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5468 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5517 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5569 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5730 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5745 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5925 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.5981 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6002 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6005 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6111 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6395 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6481 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6548 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6622 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6731 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6772 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6781 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6834 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6842 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7036 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7142 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7188 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7242 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7256 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7291 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7324 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7346 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7434 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7496 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7565 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7579 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7618 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7641 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7643 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7664 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7728 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7737 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7828 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8016 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8069 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8134 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8190 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8193 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8318 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8346 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8407 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8470 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8518 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8616 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8688 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8706 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8725 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8735 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8745 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8777 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8870 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8900 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8975 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.8988 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9116 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9195 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9196 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9222 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9250 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9277 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9575 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9638 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9651 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9773 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9810 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9845 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9928 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9928 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9934 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9948 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9960 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9978 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9979 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9987 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9993 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0000 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0007 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0029 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0036 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0137 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0208 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0231 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0305 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0315 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0355 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0358 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0433 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0513 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0532 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0536 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0548 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0574 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0596 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0614 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0667 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0734 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0776 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0795 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0813 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0865 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0883 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0894 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0900 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0901 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0903 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0961 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1020 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1032 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1067 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1070 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1139 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1189 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1227 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1267 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1332 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1354 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1361 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1434 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1450 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1552 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1597 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1703 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1779 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2024 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2146 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2176 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2239 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2305 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2340 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2341 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2376 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2503 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2523 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2524 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2564 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2596 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2634 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2673 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2692 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.2951 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3034 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3059 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3097 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3452 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3466 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3504 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3628 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3645 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3650 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3675 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3685 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3774 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3907 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.3967 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4064 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4246 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4335 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4504 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4697 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4975 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.4997 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.5232 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.5625 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.5972 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.6031 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.6139 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.6277 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.7359 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 3.7859 | scaled units | High-Dose | +4HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|